Want to join the conversation?
$MRK 2Q15 Call: From an access perspective, BELSOMRA is now covered by commercial payers, representing over 100MM lives and a branded DTC campaign will be launched next week to enhance consumer awareness. KEYTRUDA is now the number one therapy used to treat melanoma in the US and KEYTRUDA will be launched in the EU.
The latest earnings report by $VZ shows how it is losing customers despite offering the unlimited data plans, a record for the company.
$BEBE is closing down all its stores by the end of May.
$WFC agreed to hike its payout in a class-action settlement over unauthorized accounts by $32 million to $142 million for its retail sales practices. The settlement will now include customers who were impacted as early as May 2002.